Back to Polar Capital Holdings Plc Polar Capital Holdings Plc

CLDXCLDX

Showing 7 of 22 quarters

Position history for Polar Capital Holdings PlcPolar Capital Holdings Plc's holdings in Celldex Therapeutics, Inc.

No. Polar Capital Holdings exited its CLDX (Celldex Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 1,008,163 shares worth $27.4M. Polar Capital Holdings already held CLDX in its Q4 2020 13F, the earliest on record, and held it in 21 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$92.5M

Total Shares Change

-2.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$31.72
0
2025-Q4
Decreased
1M
-22.5%
$27.4M0.1%$27.16
0
2025-Q3
Increased
1.3M
+5.9%
$33.6M0.2%$25.87
37
2025-Q2
Decreased
1.2M
-12.5%
$25M0.1%$20.35
0
2025-Q1
Decreased
1.4M
-10.4%
$25.5M0.2%$18.15
0
2024-Q4
Decreased
1.6M
-42.5%
$39.6M0.2%$25.27
0
2024-Q3
Decreased
2.7M
-11.6%
$92.5M0.4%$33.99
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used